Your browser doesn't support javascript.
loading
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy.
Wang, Chenran; Huang, Maohua; Lin, Yuning; Zhang, Yiming; Pan, Jinghua; Jiang, Chang; Cheng, Minjing; Li, Shenrong; He, Wenzhuo; Li, Zhengqiu; Tu, Zhengchao; Fan, Jun; Zeng, Huhu; Lin, Jiahui; Wang, Yongjin; Yao, Nan; Liu, Tongzheng; Qi, Qi; Liu, Xiangning; Zhang, Zhimin; Chen, Minfeng; Xia, Liangping; Zhang, Dongmei; Ye, Wencai.
Afiliación
  • Wang C; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • Huang M; The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Lin Y; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Zhang Y; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • Pan J; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Jiang C; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • Cheng M; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Li S; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • He W; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Li Z; The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Tu Z; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Fan J; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • Zeng H; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Lin J; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • Wang Y; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Yao N; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Liu T; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • Qi Q; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Liu X; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • Zhang Z; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Chen M; School of Medicine, Jinan University, Guangzhou, China.
  • Xia L; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
  • Zhang D; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Ye W; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.
Nat Metab ; 5(10): 1765-1786, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37667133

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Beta Catenina / Histona Desacetilasa 1 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Metab Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Beta Catenina / Histona Desacetilasa 1 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Metab Año: 2023 Tipo del documento: Article País de afiliación: China